Compare SOTK & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOTK | DXR |
|---|---|---|
| Founded | 1975 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 73.7M | 59.0M |
| IPO Year | 1995 | 1995 |
| Metric | SOTK | DXR |
|---|---|---|
| Price | $4.94 | $10.28 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 32.9K | 8.1K |
| Earning Date | 05-27-2026 | 02-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 37.50 | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $20,909,315.00 | $1,446,345.00 |
| Revenue This Year | $4.02 | $44,935.22 |
| Revenue Next Year | $10.95 | $74.79 |
| P/E Ratio | $59.31 | ★ $33.83 |
| Revenue Growth | ★ 1.97 | N/A |
| 52 Week Low | $3.23 | $8.08 |
| 52 Week High | $5.70 | $14.76 |
| Indicator | SOTK | DXR |
|---|---|---|
| Relative Strength Index (RSI) | 52.02 | 42.52 |
| Support Level | $3.88 | $9.11 |
| Resistance Level | $5.15 | $11.23 |
| Average True Range (ATR) | 0.32 | 0.72 |
| MACD | -0.03 | -0.09 |
| Stochastic Oscillator | 35.03 | 21.63 |
Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system.